The biotech industry is expected to balloon to a massive $727B in the next five years. And along the way, we’ll also see new IPOs, technology etc … When an industry grows with that kind of speed, those who invest in the right stocks will make an awful lot of money.
Innovation in the healthcare technology field is an expanding field, with very promising possibilities. This is because current and future technologies can be applied in the daily lives of clinics, offices and hospitals, improving the quality of patient care. As in other sectors, companies that bet on innovation in health have an advantage in an increasingly competitive market.
Adoption of advanced technology and development in production are expected to play a vital role in the growth of the healthcare industry. By comparing patient data to biological recognition materials, biosensors and trackers analyze health conditions, helping to detect diseases. In the United States, they have been used for a few years to monitor symptoms in patients with conditions such as hepatitis C and AIDS.
Small and portable, this type of equipment has the potential to identify different pathologies, which makes the diagnostic faster and cheaper, which is helpful to speed up the diagnostic capabilities of any medical facility.
USA Equities Corp. (OTC: USAQ ). On December 20, 2019 USA Equities Corp entered into and consummated a share exchange with the former stockholders of Medical Practice Income (MPI) a Florida corporation. As a result of the Share Exchange, MPI became our wholly-owned-subsidiary. We are currently focused on value-based healthcare solutions, informatics and algorithmic personalized medicine including digital therapeutics, behavior based remote patient monitoring, chronic care and preventive medicine. The Company’s intellectual properties, products and information service portfolio is directed towards prevention, early detection, management and reversal of cardiometabolic and other chronic diseases. Our principle objectives are to develop proprietary software tools, devices and approaches, providing more granular, timely and specific clinical decision-making information for practicing physicians and other health care providers to address today’s now younger, obese, diabetic and cardiovascular disease population.
Now more than ever, technology and machine learning is at the forefront of patient care. Medical Practice Income addresses prevention and reduces such conditions as cardiovascular disease, diabetes, metabolic syndrome, and obesity through its innovative mobile and cloud-based software platforms.
One of the company’s recent launch is QHSLab, a Software as a Service (SaaS) platform today.
The Quality Health Score Lab Expert System (QHSLab) provides physicians and other healthcare organizations an advanced platform to capture patient information and store it in a secure, electronic database. It is then intelligently filtered, analyzed, and processed according to specific algorithms, managing large quantities of data with accuracy and precision.
QHSLab will be brought to the marketplace through approximately 150 primary care practices in Florida. Physicians, nurse practitioners, and ancillary medical practice staff will be active users of this platform, utilizing its proprietary algorithm initially for selecting appropriate allergen immunotherapy treatment sets for their patient populations.
Primary care physicians are overwhelmed by the number of patients suffering from allergies. Allergies often signal other health related concerns, indicating an immune system that is going wrong. Doctors need easy-to-use, digital medicine solutions that save time and money, while delivering the right treatment to patients that need it. Through our AI-enhanced, physician-directed platform, QHSLab, we are increasing the primary care physicians ability to more effectively address the issues with their patients, while saving patients time and expensive visits to a specialist when not absolutely necessary,” said Troy Grogan, President and CEO of Medical Practice Income, Inc.
Fredric Pullen MD, FACS, an Allergy and Ear, Nose & Throat Specialist based in Palm Beach Gardens, FL and Professor of Otolaryngology at the University of Miami Miller School of Medicine, shared the following insight regarding QHSLab: “It’s so much easier for busy primary care physicians to have a software system that can automatically generate the patient’s allergy formulas for their appropriate immunotherapy, based on their allergy test results. It saves time and potential error which is a definite plus for non-allergy specialist doctors.”
There are over 450,000 primary care physicians, including licensed nurse practitioners, in the United States. Many are reporting higher rates of fatigue and burnout due to long hours, heavy patient caseloads, and declining practice revenue from a lack of healthcare reimbursements. Digital medicine applications are a critical component to delivering quality patient care and added revenue to the physician’s practice.
With the addition of QHSLab, not only will physicians be better equipped to treat patients, but they will also be able to sustain their practices with ongoing revenue through healthcare reimbursements, generating much needed new income per practice, per year.
Grogan also shared his vision for the future of QHSLab, “We already see future iterations of QHSLab that will prove exciting additions to this innovative software platform. We will be expanding our platform to help monitor and course-correct medical conditions beyond allergies such as hypertension, cardiovascular disease, prediabetes, metabolic syndrome, anxiety and arthritis for example. We will continue our mission of focusing on prevention, and patient wellness, while supporting the frontline of healthcare, the primary care physician. We recognize the significance of the primary care physician in the healthcare system, now more than ever.”